Key result
First TPVI cases in Tanzania achieve early hemodynamic improvement and symptom relief without complications.
Why the study?
Transcatheter pulmonary valve implantation has emerged as an alternative to surgical replacement, but its adoption in low-resource settings has been limited.
Can transcatheter pulmonary valve implantation (TPVI) be safely and successfully performed to improve RVOT dysfunction in a resource-limited setting like Tanzania?
Case Report (n=2)
No
Can transcatheter pulmonary valve implantation (TPVI) be safely and successfully performed to improve RVOT dysfunction in a resource-limited setting like Tanzania?
TPVI is a feasible and safe strategy to treat right ventricular outflow tract dysfunction in resource-limited settings when supported by rigorous planning, institutional commitment, and global partnerships.
Answers are grounded in this paper and cite their sources.
Supports TPVI feasibility in resource-limited settings; leaves open scalability and durability questions.
BACKGROUND: Transcatheter pulmonary valve implantation (TPVI) has emerged as a viable alternative to surgical pulmonary valve replacement for patients with congenital heart disease and right ventricular outflow tract dysfunction. However, its adoption in low-resource settings has been limited. CASE SUMMARY: We report the first successful TPVI procedures in Tanzania. Case 1 involved a 16-year-old male with Noonan syndrome and prior homograft conduit for pulmonary atresia and ventricular septal defect. Case 2 was a 16-year-old female with repaired Tetralogy of Fallot who had undergone prior surgical valve replacement with a Trifecta valve. Both patients presented with severe right ventricular outflow tract dysfunction and underwent successful TPVI with a 20-mm Melody valve (Medtronic) without complications. Postprocedural imaging confirmed hemodynamic improvement and symptom relief. DISCUSSION: These first-in-country cases demonstrate the feasibility of TPVI in resource-limited settings. Broader implementation will require cost-reduction strategies, industry collaboration, and provider training to overcome financial and technical barriers. TAKE-HOME MESSAGE: TPVI can be safely implemented in low- and middle-income countries through structured planning and partnerships.
No takes yet. Share an insight, caveat, or question.
Unadkat et al. (2025) conducted a case report in Congenital heart disease with severe right ventricular outflow tract dysfunction (n=2). Transcatheter pulmonary valve implantation (Melody valve) was evaluated on Procedural success, hemodynamic improvement, and symptom relief. Transcatheter pulmonary valve implantation was successfully performed for the first time in Tanzania in two 16-year-old patients, resulting in significant hemodynamic improvement and symptom relief without complications at 30 days.
Synapse has enriched 10 related papers. Consider them for comparative context: